drugset / Trial / NCT05660694

Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis

NCT05660694

Phase 4 Completed 40 enrolled Altamash Institute of Dental Medicine
RandomizedParallel-groupSingle-blindTreatment

Summary

To compare the efficacy of Triamcinolone with Pentoxifylline and Vitamin E in patients with stage two and three oral submucous fibrosis.

Timeline

Start
2020-01-01
Primary completion
2021-09-30
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentoxifylline Small molecule 40 mg
Subject Triamcinolone Other / unclassified 400 mg Other
Subject Vitamin E Other / unclassified Oral